Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial.
Ralph MosgesClaus BachertP PanznerM A CalderonL HaazenS PirottonN WatheletS R DurhamM-A BonnyT LegonR von FrenckellOliver PfaarM H Mohamed ShamjiPublished in: Allergy (2018)
Lolium perenne pollen peptides administered over 3 weeks before the grass pollen season significantly reduced seasonal symptoms and was generally safe and well-tolerated.